Cite
Recurrent FXYD2 p.Gly41Arg mutation in patients with isolated dominant hypomagnesaemia.
MLA
de Baaij, Jeroen H. F., et al. “Recurrent FXYD2 p.Gly41Arg Mutation in Patients with Isolated Dominant Hypomagnesaemia.” Nephrology Dialysis Transplantation, vol. 30, no. 6, June 2015, pp. 952–57. EBSCOhost, https://doi.org/10.1093/ndt/gfv014.
APA
de Baaij, J. H. F., Dorresteijn, E. M., Hennekam, E. A. M., Kamsteeg, E.-J., Meijer, R., Dahan, K., Muller, M., van den Dorpel, M. A., Bindels, R. J. M., Hoenderop, J. G. J., Devuyst, O., & Knoers, N. V. A. M. (2015). Recurrent FXYD2 p.Gly41Arg mutation in patients with isolated dominant hypomagnesaemia. Nephrology Dialysis Transplantation, 30(6), 952–957. https://doi.org/10.1093/ndt/gfv014
Chicago
de Baaij, Jeroen H.F., Eiske M. Dorresteijn, Eric A.M. Hennekam, Erik-Jan Kamsteeg, Rowdy Meijer, Karin Dahan, Michelle Muller, et al. 2015. “Recurrent FXYD2 p.Gly41Arg Mutation in Patients with Isolated Dominant Hypomagnesaemia.” Nephrology Dialysis Transplantation 30 (6): 952–57. doi:10.1093/ndt/gfv014.